SCHEMBL6955488

SCHEMBL6955488

N#Cc1c(OCC(F)(F)F)nc(NCCOc2ccccn2)nc1N1CCc2ccccc2CC1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AURKA O14965 1/20 0.38
CYP3A4 P08684 1/20 0.38
CYP2D6 P10635 1/20 0.38
KDM4E B2RXH2 3/20 0.37
ALDH1A1 P00352 2/20 0.37
MEN1 O00255 2/20 0.37
KMT2A Q03164 2/20 0.37
TP53 P04637 1/20 0.37
MAPT P10636 1/20 0.37
HPGD P15428 1/20 0.37
HTT P42858 1/20 0.37
HSD17B10 Q99714 1/20 0.37
TRPV1 Q8NER1 2/20 0.35
PIK3CD O00329 1/20 0.33
KDM6B O15054 3/20 0.32
PLK1 P53350 1/20 0.32
APAF1 O14727 1/20 0.32
CASP3 P42574 1/20 0.32
CASP6 P55212 1/20 0.32
SENP8 Q96LD8 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6945704 0.86 GRIN2D (0.41) KDM4EALDH1A1MEN1KMT2ATP53
SCHEMBL6951267 0.85 ALDH1A1 (0.40) KDM4EALDH1A1MEN1KMT2ATP53
SCHEMBL6945718 0.84 ALDH1A1 (0.40) KDM4EALDH1A1MEN1KMT2ATP53
SCHEMBL6948041 0.83 ABCC1 (0.41) KDM4EALDH1A1MEN1KMT2ATP53
SCHEMBL6947660 0.81 OGA (0.40) HTR2AHTR2CHTR2B
SCHEMBL6949377 0.81 MEN1 (0.42) CYP3A4CYP2D6KDM4EALDH1A1MEN1
SCHEMBL6949140 0.80 PLK1 (0.39) KDM4EALDH1A1MEN1KMT2ATP53
SCHEMBL6953994 0.80 GLA (0.41) KDM4EALDH1A1KMT2AMAPTHPGD
SCHEMBL6952835 0.80 KDM4E (0.43) KDM4EALDH1A1MEN1KMT2AMAPT
SCHEMBL6952840 0.79 PIK3CD (0.38) KDM4EALDH1A1MEN1KMT2ATP53

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1074549-B1 Tetrahydro-benzo(d)azepines and their use as antagonists at metabotropic glutamate receptors HOFFMANN LA ROCHE (CH) 2003-11-19 EP disclosed
US-6218385-B1 FOR THERAPY OR PROPHYLAXIS OF ACUTE AND/OR CHRONIC NEUROLOGICAL DISORDERS SUCH AS EPILEPSY, STROKE, CHRONIC AND ACUTE PAIN, PSYCHOSIS, SCHIZOPHRENIA, ALZHEIMER'S DISEASE, COGNITIVE DISORDERS AND MEMORY DEFICITS HOFFMANN-LA ROCHE INC. 2001-04-17 US disclosed
EP-1074549-A2 Tetrahydro-benzo(d)azepines and their use as antagonists at metabotropic glutamate receptors F. HOFFMANN-LA ROCHE AG (CH) 2001-02-07 EP disclosed